Clinical value of transferring blastocysts derived from 0PN/1PN or grade III embryos

Jinpeng Rao,Feng Qiu,Shen Tian,Yiting Cai,Chun Feng,Fan Jin,Min Jin
2020-01-01
Abstract:The aim of this study was to characterize blastocyst formation from Day 1 abnormal pronuclear (0PN/1PN) embryos or Day 3 poor-quality (2PN grade III) embryos and establish the clinical outcomes following transfer of these embryos. We retrospectively analyzed blastocyst formation from Day 3 cleaved embryos derived from 0PN (group A), 1PN (group B), 2PN grade III (group C) and 2PN grade I/II (group D) following ART (assisted reproductive technology) cycles. To establish embryo transfer outcomes, clinical data associated with the transfer of frozenthawed useable blastocysts from the four groups were analyzed. Results showed that blastocyst formation rate, useable blastocyst formation rate and high-quality blastocyst formation rate were significantly lower in group A, B and C compared to group D (P < 0.001). Useable blastocyst formation rate and high-quality blastocyst formation rate were significantly higher in group A relative to group C (P = 0.001). Differences in clinical pregnancy rate, embryo implantation rate, ongoing pregnancy rate and abortion rate among the four groups were not significantly different (P > 0.05). No defects, such as malformations were observed in the newborns. In conclusion, even though 0PN/1PN or grade III embryos have significantly lower development potential, near-normal clinical outcomes may be achieved when they are cultured to the useable blastocyst stage, improving chances of success.
What problem does this paper attempt to address?